在真菌病原体中的葡萄糖载体和传感器机制作为潜在的药物点
1Department of Pharmacology, Parul Institute of Pharmacy, Parul University, Limda, India.
Current reviews in clinical and experimental pharmacology
|October 20, 2023
概括
新的抗真菌药物标因耐药性增加至关重要. 本综述详细介绍了真菌葡萄糖运输机制,强调它们作为抗真菌药物开发的新目标的潜力.
科学领域:
- 菌类学 菌类学是指菌类学.
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- 真菌感染对全球健康构成重大挑战,因抗真菌耐药性增加而加剧.
- 目前的抗真菌疗法受到药物耐药性,副作用和缺乏疗效的限制.
- 葡萄糖对于真菌的生存至关重要,它影响病毒性,生长,入侵,生物膜形成和耐药性.
研究的目的:
- 提供关于真菌病原体中糖运输机制的全面审查.
- 通过探索真菌葡萄糖进入途径,识别潜在的新型抗真菌药物标.
- 为目标药物开发突出人类和真菌葡萄糖运输体之间的结构差异.
主要方法:
- 关于真菌糖运输的科学出版物的文献综述.
- 对详细描述病原性真菌葡萄糖吸收和感知机制的研究进行分析.
- 人类与真菌葡萄糖转运器结构的比较分析.
主要成果:
- 菌类拥有复杂的葡萄糖运输和感应系统,这对于它们的生存至关重要.
- 调节这些葡萄糖通路是抑制真菌生长的有希望的策略.
- 菌类葡萄糖运输体的独特结构特征为选择性药物向提供了机会.
结论:
- 针对真菌的葡萄糖运输机制是开发新抗真菌剂的新且可行的策略.
- 了解真菌糖的进入途径对于解决抗真菌耐药性的挑战至关重要.
- 对真菌葡萄糖载体的进一步研究可能会导致开发急需的抗真菌药物.
相关概念视频
Glucose Transporters
22.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.8K
Secondary Active Transport
7.1K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
7.1K
Glucose Absorption Into the Small Intestine
31.8K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.8K
Membrane Proteins
20.5K
Plasma membranes have integral transmembrane proteins involved in facilitated transport. These proteins are collectively referred to as transport proteins, and they function as either channels for the material or as carriers themselves. Channel proteins have hydrophilic domains exposed to the intracellular and extracellular fluids and a hydrophilic channel through their core that provides a hydrated opening for solutes to pass through the membrane layers. Passage through the channel allows...
20.5K
Glucose Homeostasis: Regulation of Blood Glucose
1.7K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.7K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K


